Formulation Effects on the Thermomechanical Properties and Permeability of Free Films and Coating Films: Characterization of Cellulose Acetate Films - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Formulation Effects on the Thermomechanical Properties and Permeability of Free Films and Coating Films: Characterization of Cellulose Acetate Films
The authors investigate the effects of a polyethylene glycol plasticizer and water on cellulose acetate film properties.

Pharmaceutical Technology
Volume 33, Issue 3, pp. 88-100


Understanding formulation factor effects on free-film and coating-film properties would provide guidelines for selecting a formulation in the early design stage of developing semipermeable membranes. The results from this study demonstrated that formulation factors such as plasticizer and water level, signifantly affect free-film properties and coating performance. With increasing plasticizer level, the mechanical strength of the free films decreased and the permeability of the films increased. With the interaction of plasticizer and water, the effects on the properties of free films were even greater. Although there were no significant differences in free film properties between CA-398-10NF-EP and CA-398-10TG, the permeability of coating films increased with decreasing acetyl content in CA polymers. The acetyl content over a range of about 1.0% affected permeability of coating films at some degree and the effects were largely dependent on the formulation. With higher plasticizer level and water level in the formulation, the acetyl content only slightly affected the permeability of the coating film. This study demonstrates that it is important to design a robust formulation to reduce the variability of a finished product. It should be realized that besides formulation factors, processing conditions are key controls in ensuring product quality and keeping the release profile of a product in a desirable range.

Jinghua Yuan* is a principal technical service representative, Doug Dunn is a senior lab technician, Nancy M. Clipse is a research analyst, and Ray J. Newton, Jr. is a senior research associate, all at Formulation Products Lab, Pharmaceutical Formulations Group, Eastman Chemical Company, Kingsport, TN 37662, tel. 423.229.8627, fax 423.224.0414,

*To whom all correspondence should be addressed.

Submitted: May 6, 2008. Accepted: Oct. 1, 2008.

What would you do differently? Submit your comments about this paper in the space below.


1. N. Ramakrishna and B. Mishra, "Plasticizer Effect and Comparative Evaluation of Cellulose Acetate and Ethylcellulose-HPMC Combination Coatings as Semipermeable Membranes for Oral Osmotic Pumps of Naproxen Sodium," Drug Dev. Ind. Pharm. 28 (4), 403–412 (2002).

2. G. Deepak and P. Kilambi, "The Fabrication and Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System," Pharm. Technol. 27 (9), 58–68 (2003).

3. S.N. Makhija and P.R. Vavia, "Controlled Porosity Osmotic Pump-Based Controlled Release Systems of Pseuoephedrine I. Cellulose Acetate as a Semipermeable Membrane," J. Controlled Release 89, 5–18 (2003).

4. T. Guyonnet, C. Brossard, and D. Lefort des Ylouses, "Prolongation of Release of Theophylline Derivatives from Cellulose Acetate-based Tablets," J. Pharmacie de Belgiue 45 (2), 111–119 (1990).

5. O.Y. Abdallah, N.A. Boraie, and V.F. Naggar, "Preparation and Evaluation of Metformin Hydrochloride Controlled-Release Tablets," S.T.P. Pharma 4 (1), 15–20 (1988).

6. M. Corbo et al. "Taste Masking Coating Composition Based on Methacrylate polymer and Cellulose Ester," World Patent No. 2001080826 (2001).

7. M.R. Hoy and E.J. Roche, "Taste Mask Coatings for Preparation of Chewable Pharmaceutical Tablets," US Patent No. 5489436 (1996).

8. E.J. Roche, "Taste Masking and Sustained-Release Coatings Containing Cellulose Derivatives for Pharmaceuticals," Europe Patent No. 459695 (1991).

9. R.K. Verma, D.M. Krishna, and S. Gard, "Formulation Aspects in the Development of Osmotically Controlled Oral Drug Delivery Systems," J. Controlled Release 79, 7–27 (2002).

10. G. Santus and R.W. Baker, "Osmotic Drug Delivery: A Review of the Patent Literature," J. Controlled Release 35, 1–21 (1995).

11. A.M. Kaushal and S. Garg, "An Update on Osmotic Drug Delivery Patents," Pharm. Technol. 27 (8), 38–97 (2003).

12. J. Yuan, P.P. Shang, and S.H. Wu, "Effects of Polyethylene Glycol on Morphology, Thermomechanical Properties, and Water Vapor Permeability of Cellulose Acetate-Free Films," Pharm. Technol. 25 (10), 62–74 (2001).

13. M.M. Meier et al., "Poly(caprolactone triol) as Plasticizer Agent for Cellulose Acetate Films: Influence of the Preparation Procedure and Plasticizer Content on the Physicochemical Properties," Poly. Adv. Technol. 15 (10), 593–600 (2004).

14. M.M. Meier, L.A. Kanis, and V. Soldi, "Characterization and Drug-permeation Profiles of Microporous and Dense Cellulose Acetate Membranes: Influence of Plasticizer and Pore Forming Agent," Int. J. Pharma. 278, 99–110 (2004).

15. J. Yuan and S.H. Wu, "Sustained-Release Tablets via Direct Compression: A Feasibility Study Using Cellulose Acetate and Cellulose Acetate Butyrate," Pharm. Technol. 24 (10), 92–106 (2000).

16. J. Yuan and J. Zhu, "Investigation of the Opaqueness in Cellulose Acetate 398-10NF Free Films: Water Effects," Eastman Technical Report TR-2005-04061 (2005).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here